{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:20:26Z","timestamp":1790835626139,"version":"4.1.0"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["017.008.014"],"award-info":[{"award-number":["017.008.014"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["91919149"],"award-info":[{"award-number":["91919149"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022115","name":"Dutch Arthritis Association","doi-asserted-by":"publisher","award":["NR-10-1-301"],"award-info":[{"award-number":["NR-10-1-301"]}],"id":[{"id":"10.13039\/501100022115","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000654","name":"Marie Curie","doi-asserted-by":"publisher","award":["624871"],"award-info":[{"award-number":["624871"]}],"id":[{"id":"10.13039\/501100000654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/93526\/2013"],"award-info":[{"award-number":["SFRH\/BD\/93526\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imlet.2017.11.003","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T23:12:21Z","timestamp":1510096341000},"page":"18-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Dendritic cells in systemic sclerosis: Advances from human and mice studies"],"prefix":"10.1016","volume":"195","author":[{"given":"Alsya J.","family":"Affandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Carvalheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.D.J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioleta","family":"Marut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2017.11.003_bib0005","first-page":"1","article-title":"Systemic sclerosis","volume":"6736","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2017.11.003_bib0010","first-page":"481","article-title":"Novel insights on the role of the innate immune system in systemic sclerosis., Expert Rev","volume":"7","author":"York","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/BOR.0b013e32834b0dac","article-title":"An update on an immune system that goes awry in systemic sclerosis","volume":"23","author":"van Bon","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.lpm.2014.08.001","article-title":"Pathophysiology of systemic sclerosis: state of the artin 2014","volume":"43","author":"Dumoitier","year":"2014","journal-title":"Press. Medicale."},{"key":"10.1016\/j.imlet.2017.11.003_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-011-0215-5","article-title":"Dendritic cells: novel players in fibrosis and scleroderma","volume":"14","author":"Lu","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.imlet.2017.11.003_bib0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0035","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jdermsci.2014.08.012","article-title":"Human skin dendritic cells in health and disease","volume":"77","author":"Haniffa","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.imlet.2017.11.003_bib0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coi.2013.11.002","article-title":"Organization of the mouse and human DC network","volume":"26","author":"Schlitzer","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0045","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.11.003_bib0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fimmu.2014.00131","article-title":"Human dendritic cell functional specialization in steady-state and inflammation","volume":"5","author":"Boltjes","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","article-title":"Type I interferons: crucial participants in disease amplification in autoimmunity","volume":"6","author":"Hall","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0060","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nri3865","article-title":"The multifaceted biology of plasmacytoid dendritic cells","volume":"15","author":"Swiecki","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3683","article-title":"The origins and functions of dendritic cells and macrophages in the skin","volume":"14","author":"Malissen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.immuni.2014.08.006","article-title":"Human dermal CD14+ cells are a transient population of monocyte-derived macrophages","volume":"41","author":"McGovern","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.11.003_bib0075","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"Lowes","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.11.003_bib0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"Zaba","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.1780370218","article-title":"Immunocytochemical localization and serologic detection of transforming growth factor beta 1. Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud\u2019s phenomenon","volume":"37","author":"Higley","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0090","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archderm.1994.01690050061010","article-title":"CD34+ spindle-shaped cells selectively disappear from the skin lesion of scleroderma","volume":"130","author":"Aiba","year":"1994","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0095","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/DAD.0b013e3182712d1a","article-title":"Dermal dendritic cell population and blood vessels are diminished in the skin of systemic sclerosis patients: relationship with fibrosis degree and disease duration","volume":"35","author":"de-S\u00e1-Earp","year":"2013","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0100","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI32282","article-title":"Normal human dermis contains distinct populations of CD11c + BDCA-1+ dendritic cells and CD163 + FXIIIA+ macrophages","volume":"117","author":"Zaba","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.11.003_bib0105","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.23451","article-title":"Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma","volume":"58","author":"Duan","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0110","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1371\/journal.pone.0001452","article-title":"Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?","volume":"3","author":"Fleming","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.11.003_bib0115","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0120","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1523-1747.2002.19515.x","article-title":"Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases","volume":"119","author":"Wollenberg","year":"2002","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0625.2012.01475.x","article-title":"Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea","volume":"21","author":"Ghoreishi","year":"2012","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0130","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/art.40163","article-title":"Association of microRNA-618 expression with altered frequency and activation of plasmacytoid dendritic cells in patients with systemic sclerosis","volume":"69","author":"Rossato","year":"2017","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.imlet.2017.11.003_bib0135","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/art.11225","article-title":"Expression of the markers BDCA-2 and BDCA-4 and production of interferon-\u03b1 by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"48","author":"Blomberg","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0140","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-\u03b1 production","volume":"202","author":"Nestle","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0145","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1136\/annrheumdis-2012-202814","article-title":"Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin","volume":"73","author":"Mathes","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0150","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2004.06.014","article-title":"CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions","volume":"21","author":"Ohl","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.11.003_bib0155","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20020437","article-title":"The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)\/CXCL12","volume":"198","author":"Vanbervliet","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0160","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/art.22047","article-title":"Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications","volume":"54","author":"Cipriani","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0165","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2017.11.003_bib0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/03009740802572467","article-title":"Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion","volume":"38","author":"van Lieshout","year":"2009","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0175","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/ard.2009.128207","article-title":"Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis","volume":"69","author":"van Bon","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0180","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.33325","article-title":"A rare polymorphism in the gene for toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators","volume":"64","author":"Broen","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0185","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/annrheumdis-2013-205013","article-title":"Proteomic analysis of plasma identifies the toll-like receptor agonists S100A8\/A9 as a novel possible marker for systemic sclerosis phenotype","volume":"73","author":"van Bon","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0190","article-title":"Endogenous ligands of TLR4 promote unresolving tissue fibrosis: implications for systemic sclerosis and its targeted therapy","author":"Bhattacharyya","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2017.11.003_bib0195","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20140467","article-title":"Pound the alarm: danger signals in rheumatic diseases","volume":"128","author":"O\u2019Reilly","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.imlet.2017.11.003_bib0200","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/imm.12260","article-title":"Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-\u03baB","volume":"143","author":"O\u2019Reilly","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2017.11.003_bib0205","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar4598","article-title":"Chronic toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis","volume":"16","author":"Stifano","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.003_bib0210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-like receptor 4 signaling augments transforming growth factor-\u03b2 responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0215","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1038\/jid.2010.200","article-title":"Poly(I:C) drives type I IFN- and TGF\u03b2-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis","volume":"130","author":"Farina","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0220","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-015-0785-0","article-title":"CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis","volume":"17","author":"Mokuda","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.003_bib0225","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.39817","article-title":"Platelets induce thymic stromal lymphopoietin production by endothelial cells: contribution to fibrosis in human systemic sclerosis","volume":"68","author":"Truchetet","year":"2016","journal-title":"Arthritis Rheumatol. (Hoboken, N. J.)"},{"key":"10.1016\/j.imlet.2017.11.003_bib0230","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1136\/annrheumdis-2012-202279","article-title":"A profibrotic role for thymic stromal lymphopoietin in systemic sclerosis","volume":"72","author":"Usategui","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0235","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/art.37859","article-title":"Thymic stromal lymphopoietin is up-regulated in the skin of patients with systemic sclerosis and induces profibrotic genes and intracellular signaling that overlap with those induced by interleukin-13 and transforming growth factor \u03b2","volume":"65","author":"Christmann","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0240","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1038\/ncomms3847","article-title":"Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade","volume":"4","author":"Leyva-Castillo","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2017.11.003_bib0245","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/art.38338","article-title":"Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells","volume":"66","author":"Moret","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0250","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.30318","article-title":"Interferon and alternative activation of monocyte\/macrophages in systemic sclerosis-associated pulmonary arterial hypertension","volume":"63","author":"Christmann","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0255","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0260","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/rheumatology\/kei244","article-title":"Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients","volume":"45","author":"Tan","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2017.11.003_bib0265","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/art.23486","article-title":"Induction of interferon-alpha by scleroderma sera containing autoantibodies to topoisomerase I: association of higher interferon-alpha activity with lung fibrosis","volume":"58","author":"Kim","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0270","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0275","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2017.11.003_bib0280","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA\u2013antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"Ganguly","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0285","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/bjd.14699","article-title":"A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis","volume":"175","author":"Takahashi","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"Suppl. 10","key":"10.1016\/j.imlet.2017.11.003_bib0290","article-title":"Plasmacytoid dendritic cells are activated in systemic sclerosis and contribute to the disease by inducing Ifn\u03b1 and CXCL4 [abstract]","volume":"68","author":"Kioon","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0295","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3899\/jrheum.160833","article-title":"Proteomic analysis of sera from individuals with diffuse cutaneous systemic sclerosis reveals a multianalyte signature associated with clinical improvement during imatinib mesylate treatment","volume":"44","author":"Haddon","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13075-016-1203-y","article-title":"Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease","volume":"18","author":"Volkmann","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.003_bib0305","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/annrheumdis-2017-eular.4066","article-title":"Type I interferon signature in the peripheral blood and CXCL4 plasma levels in patients with systemic sclerosis","volume":"76","author":"Vlachogiannis","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0310","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/rheumatology\/kew251","article-title":"Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?","volume":"55","author":"van Bon","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2017.11.003_bib0315","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4049\/jimmunol.1602020","article-title":"CXCL4 exposure potentiates TLR-driven polarization of human monocyte-derived dendritic cells and increases stimulation of T cells","volume":"199","author":"Silva-Cardoso","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0320","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/art.39830","article-title":"Editorial: epigenetics in systemic sclerosis","volume":"68","author":"Lafyatis","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0325","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00281-015-0504-6","article-title":"Epigenetics and systemic sclerosis","volume":"37","author":"Altorok","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0330","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","article-title":"The role of genetics and epigenetics in the pathogenesis of systemic sclerosis","volume":"10","author":"Broen","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0335","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.immuni.2016.08.013","article-title":"IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells, respectively","volume":"45","author":"Sichien","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.11.003_bib0340","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/stem.2565","article-title":"Modelling IRF8 deficient human hematopoiesis and dendritic cell development with engineered iPS cells","volume":"35","author":"Sontag","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.imlet.2017.11.003_bib0345","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/art.39655","article-title":"Toll-like receptor 9 signaling is augmented in systemic sclerosis and elicits transforming growth factor \u03b2-dependent fibroblast activation","volume":"68","author":"Fang","year":"2016","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"key":"10.1016\/j.imlet.2017.11.003_bib0350","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.290.5489.84","article-title":"Immune inhibitory receptors","volume":"290","author":"Ravetch","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.11.003_bib0355","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrrheum.2016.131","article-title":"Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?","volume":"12","author":"van der Vlist","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0360","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s13075-014-0469-1","article-title":"Immune checkpoint receptors in regulating immune reactivity in rheumatic disease","volume":"16","author":"Ceeraz","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.003_bib0365","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pharmthera.2009.10.007","article-title":"Inhibitory receptors on myeloid cells: new targets for therapy?","volume":"125","author":"Munitz","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.imlet.2017.11.003_bib0370","doi-asserted-by":"crossref","first-page":"e15080","DOI":"10.1371\/journal.pone.0015080","article-title":"The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFN\u03b1 production","volume":"5","author":"Bonaccorsi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.11.003_bib0375","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.4049\/jimmunol.1700271","article-title":"The role of leukocyte-associated Ig-like receptor-1 in suppressing collagen-induced arthritis","volume":"199","author":"Kim","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0380","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clim.2008.06.004","article-title":"TLR9\/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients","volume":"129","author":"Wu","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0385","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.humimm.2015.09.040","article-title":"Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren\u2019s syndrome","volume":"76","author":"Liu","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0390","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1538\/expanim.14-0079","article-title":"Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor","volume":"64","author":"Seno","year":"2015","journal-title":"Exp. Anim."},{"key":"10.1016\/j.imlet.2017.11.003_bib0395","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.molimm.2015.10.007","article-title":"DCIR negatively regulates CpG-ODN-induced IL-1\u03b2 and IL-6 production","volume":"68","author":"Zhao","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0400","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nm1697","article-title":"Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells","volume":"14","author":"Fujikado","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0405","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1165\/rcmb.2012-0329OC","article-title":"Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages","volume":"48","author":"Karo-Atar","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0410","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1053\/j.gastro.2010.04.006","article-title":"Paired immunoglobulin-like receptor B (PIR-B) negatively regulates macrophage activation in experimental colitis","volume":"139","author":"Munitz","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imlet.2017.11.003_bib0415","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ni801","article-title":"Impaired dendritic cell maturation and increased TH2 responses in PIR-B-\/- mice","volume":"3","author":"Ujike","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0420","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1182\/blood-2012-03-419093","article-title":"Regulation of plasmacytoid dendritic cell responses by PIR-B","volume":"120","author":"Mitsuhashi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.11.003_bib0425","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nri3582","article-title":"The function of Fc\u03b3 receptors in dendritic cells and macrophages","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0430","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0435","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1002\/art.22275","article-title":"The functional variant of the inhibitory Fc gamma receptor IIb (CD32B) is associated with the rate of radiologic joint damage and dendritic cell function in rheumatoid arthritis","volume":"54","author":"Radstake","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0440","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.4049\/jimmunol.0900153","article-title":"The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease","volume":"183","author":"Wenink","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0445","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2567.2009.03138.x","article-title":"Disease activity in systemic lupus erythematosus is associated with an altered expression of low-affinity Fc\u03b3 receptors and costimulatory molecules on dendritic cells","volume":"128","author":"Carre\u00f1o","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2017.11.003_bib0450","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/1346-8138.12651","article-title":"Serum levels of anti-Fc\u03b3 receptor IIB\/C antibodies are increased in patients with systemic sclerosis","volume":"41","author":"Kadono","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0455","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.immuni.2015.07.009","article-title":"Protein tyrosine phosphatase PTPRS is an inhibitory receptor on human and murine plasmacytoid dendritic cells","volume":"43","author":"Bunin","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.11.003_bib0460","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1164\/rccm.200907-1164OC","article-title":"A role for dendritic cells in bleomycin-induced pulmonary fibrosis in mice?","volume":"182","author":"Bantsimba-Malanda","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0465","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.immuni.2017.08.016","article-title":"Aryl hydrocarbon receptor controls monocyte differentiation into dendritic cells versus macrophages","volume":"47","author":"Goudot","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.11.003_bib0470","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1089\/scd.2013.0521","article-title":"The aryl hydrocarbon receptor antagonist Stemregenin 1 promotes human plasmacytoid and myeloid dendritic cell development from CD34+ hematopoietic progenitor cells","volume":"23","author":"Thordardottir","year":"2014","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.imlet.2017.11.003_bib0475","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.smim.2015.10.002","article-title":"Aryl hydrocarbon receptor: linking environment to immunity","volume":"27","author":"Cella","year":"2015","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0480","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1164\/rccm.200503-468OC","article-title":"A novel low molecular weight inhibitor of dendritic cells and B cells blocks allergic inflammation","volume":"173","author":"Ettmayer","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0485","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2007-08-109843","article-title":"Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells","volume":"112","author":"Hauben","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.11.003_bib0490","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.humimm.2012.05.002","article-title":"The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and na\u00efve CD4+ Th cells to promote the development of IL-22-secreting Th cells","volume":"73","author":"Baba","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0495","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cbin.10800","article-title":"Modulation of CD11c+ lung dendritic cells in respect to TGF-\u03b2 in experimental pulmonary fibrosis","volume":"41","author":"Chakraborty","year":"2017","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.imlet.2017.11.003_bib0500","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4049\/jimmunol.1502479","article-title":"Bone marrow CD11c+ cell-derived amphiregulin promotes pulmonary fibrosis","volume":"197","author":"Ding","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0505","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00281-015-0506-4","article-title":"Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment","volume":"37","author":"Affandi","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0510","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/art.20962","article-title":"Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma","volume":"52","author":"Chen","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0515","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.4049\/jimmunol.166.9.5456","article-title":"Distinct autoreactive T cell responses to native and fragmented DNA topoisomerase I: influence of APC type and IL-2","volume":"166","author":"Oriss","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0520","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/08916934.2016.1230848","article-title":"Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis","volume":"49","author":"Mehta","year":"2016","journal-title":"Autoimmunity"},{"key":"10.1016\/j.imlet.2017.11.003_bib0525","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.4049\/jimmunol.1103538","article-title":"Arsenic trioxide prevents murine sclerodermatous graft-versus-host disease","volume":"188","author":"Kavian","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0530","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature12614","article-title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma","volume":"503","author":"Gerber","year":"2013","journal-title":"Nature"},{"issue":"Suppl. 10","key":"10.1016\/j.imlet.2017.11.003_bib0535","article-title":"Plasmacytoid dendritic cells in systemic fibrosis: pathogenic role in bleomycin-induced fibrosis model and correlation with disease in patients with systemic sclerosis [abstract]","volume":"69","author":"Kafaja","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0540","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1172\/JCI85740","article-title":"Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis","volume":"126","author":"Chia","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.11.003_bib0545","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/icb.2011.46","article-title":"Sclerodermatous chronic graft-versus-host disease induced by host T-cell-mediated autoimmunity","volume":"90","author":"Lee","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0550","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood-2015-11-680876","article-title":"Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD","volume":"128","author":"Leveque-El Mouttie","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2017.11.003_bib0555","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4049\/jimmunol.1502190","article-title":"Type I IFNs regulate inflammation, vasculopathy, and fibrosis in chronic cutaneous graft-versus-host disease","volume":"197","author":"Delaney","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0560","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1136\/annrheumdis-2015-208213","article-title":"Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosis","volume":"75","author":"Ponsoye","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0565","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-015-0669-3","article-title":"Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis","volume":"17","author":"Chakravarty","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.003_bib0570","unstructured":"US National Library of Medicine, ClinicalTrials.gov. 2015. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02161406."},{"key":"10.1016\/j.imlet.2017.11.003_bib0575","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0580","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.autrev.2010.08.003","article-title":"Relationship between cytokine profiles and clinical outcomes in patients with systemic sclerosis","volume":"10","author":"Baraut","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.11.003_bib0585","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1002\/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K","article-title":"Increased interleukin-17 production in patients with systemic sclerosis","volume":"43","author":"Kurasawa","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0590","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4049\/jimmunol.1004081","article-title":"Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and \u2212independent mechanisms","volume":"187","author":"Mi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0595","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0600","doi-asserted-by":"crossref","first-page":"e5903","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.11.003_bib0605","doi-asserted-by":"crossref","first-page":"e23185","DOI":"10.1371\/journal.pone.0023185","article-title":"IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis","volume":"6","author":"Gasse","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.11.003_bib0610","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2017.11.003_bib0615","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/ar4430","article-title":"Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction","volume":"16","author":"Yang","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.003_bib0620","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humimm.2014.12.008","article-title":"The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis","volume":"76","author":"Zhou","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0625","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3899\/jrheum.090421","article-title":"Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis","volume":"36","author":"Agarwal","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0630","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrrheum.2014.106","article-title":"Advances in the management of psoriatic arthritis","volume":"10","author":"Olivieri","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0635","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","volume":"371","author":"Papp","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2017.11.003_bib0640","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1\u00dayear results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial","volume":"382","author":"McInnes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2017.11.003_bib0645","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa1607017","article-title":"Risankizumab versus ustekinumab for moderate-to-severe plaque psoriasis","volume":"376","author":"Papp","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0650","first-page":"1","article-title":"Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials","volume":"6736","author":"Reich","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2017.11.003_bib0655","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/ar4492","article-title":"Dose-escalation of human anti-interferon-\u03b1 receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study","volume":"16","author":"Goldberg","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.003_bib0660","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.11.003_bib0665","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2017.11.003_bib0670","first-page":"1","article-title":"Use of biologics and other novel therapies for the treatment of systemic sclerosis","volume":"13","author":"Bruni","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0675","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.autrev.2013.09.008","article-title":"Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?","volume":"13","author":"Van Brussel","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.11.003_bib0680","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11926-015-0555-7","article-title":"Cellular therapies in systemic sclerosis: recent progress","volume":"18","author":"van Rhijn-Brouwer","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.imlet.2017.11.003_bib0685","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2014.10.010","article-title":"Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases","volume":"14","author":"Mackern-Oberti","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2017.11.003_bib0690","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.4049\/jimmunol.1002497","article-title":"TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment","volume":"186","author":"Bonnefoy","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0695","first-page":"290ra87","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","author":"Benham","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0700","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0705","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I. (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.imlet.2017.11.003_bib0710","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ecco-jcc\/jjv144","article-title":"Intraperitoneal administration of autologous tolerogenic dendritic cells for refractory crohn\u2019s disease: a phase I study","volume":"9","author":"Jauregui-Amezaga","year":"2015","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.imlet.2017.11.003_bib0715","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fimmu.2014.00287","article-title":"Application of antigen cross-presentation research into patient care","volume":"5","author":"Flinsenberg","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/2162402X.2017.1386829","article-title":"Trial watch: dendritic cell-based anticancer immunotherapy","volume":"6","author":"Garg","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.imlet.2017.11.003_bib0725","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nri3727","article-title":"Dendritic cell-targeted vaccines\u2013hope or hype?","volume":"14","author":"Kastenm\u00fcller","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0730","doi-asserted-by":"crossref","DOI":"10.1189\/jlb.5MR0217-059RR","article-title":"Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines","volume":"102","author":"van Dinther","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0735","first-page":"844","article-title":"Specialized role of migratory dendritic cells in peripheral tolerance induction","volume":"123","author":"Idoyaga","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2017.11.003_bib0740","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.4049\/jimmunol.1400986","article-title":"DEC205\u2009+\u2009dendritic cell\u2013targeted tolerogenic vaccination promotes immune tolerance in experimental autoimmune arthritis","volume":"194","author":"Spiering","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0745","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nri2056","article-title":"Siglecs and their roles in the immune system","volume":"7","author":"Crocker","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0750","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1073\/pnas.1507706113","article-title":"Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells","volume":"113","author":"Perdicchio","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.11.003_bib0755","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.4049\/jimmunol.1102307","article-title":"Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity","volume":"187","author":"Loschko","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0760","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.4049\/jimmunol.1004029","article-title":"Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity","volume":"186","author":"Loschko","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0765","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/eji.201242799","article-title":"Targeting antigen to bone marrow stromal cell-2 expressed by conventional and plasmacytoid dendritic cells elicits efficient antigen presentation","volume":"43","author":"Moffat","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0770","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2014.00055","article-title":"Self-antigen presentation by dendritic cells in autoimmunity","volume":"5","author":"Hopp","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0775","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2017.11.003_bib0780","first-page":"356","article-title":"Mapping the human DC lineage through the integration of high-dimensional techniques","author":"See","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.11.003_bib0785","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.4049\/jimmunol.0802008","article-title":"CD2 distinguishes two subsets of human plasmacytoid dendritic cells with distinct phenotype and functions","volume":"182","author":"Matsui","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0790","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1073\/pnas.1610630114","article-title":"A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2017.11.003_bib0795","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nmeth.2563","article-title":"In situ sequencing for RNA analysis in preserved tissue and cells","volume":"10","author":"Ke","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.imlet.2017.11.003_bib0800","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.1250212","article-title":"Highly multiplexed subcellular RNA sequencing in situ","volume":"343","author":"Lee","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.imlet.2017.11.003_bib0805","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrrheum.2016.68","article-title":"The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions","volume":"12","author":"Abdollahi-Roodsaz","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0810","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ni.3780","article-title":"Regulation of inflammation by microbiota interactions with the host","volume":"18","author":"Blander","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0815","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature14052","article-title":"Commensal\u2013dendritic-cell interaction specifies a unique protective skin immune signature","volume":"520","author":"Naik","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2017.11.003_bib0820","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-016-1182-z","article-title":"Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease","volume":"18","author":"Andr\u00e9asson","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.003_bib0825","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.39572","article-title":"Association of systemic sclerosis with a unique colonic microbial consortium","volume":"68","author":"Volkmann","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0830","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nm.4102","article-title":"CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands","volume":"22","author":"Lamas","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2017.11.003_bib0835","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOR.0000000000000218","article-title":"Update on macrophages and innate immunity in scleroderma","volume":"27","author":"Chia","year":"2015","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0840","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.it.2007.07.006","article-title":"Dendritic cell\u2013endothelial cell cross-talk in angiogenesis","volume":"28","author":"Sozzani","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2017.11.003_bib0845","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1189\/jlb.3A1015-474R","article-title":"Stromal fibroblasts support dendritic cells to maintain IL-23\/Th17 responses after exposure to ionizing radiation","volume":"100","author":"Malecka","year":"2016","journal-title":"J. Leukoc. Biol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817302900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:44:29Z","timestamp":1778503469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817302900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":169,"alternative-id":["S0165247817302900"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.003","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cells in systemic sclerosis: Advances from human and mice studies","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}